Identification of key target genes and biological pathways in multiple sclerosis brains using microarray data obtained from the Gene Expression Omnibus database.

CONCLUSION: Several key target genes and their GO and KEGG pathway enrichment identified in the present study may serve as feasible targets for MS therapies. PMID: 30074468 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30074468?dopt=Abstract

Source: Neurological Research - August 5, 2018 Category: Neurology Tags: Neurol Res Source Type: research